Alain Algazi

MD

Medical oncologist
Immunologist, father and rather slow endurance athlete

About me

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee.

In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy.

Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF.

Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research.

To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900.

  • Education

    UCLA School of Medicine, 2004

  • Residencies

    UCLA Medical Center, Internal Medicine, 2007

  • Fellowships

    UCSF, Hematology-Oncology, 2010

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

There is a cure for every cancer. Our job is to find it.

My reviews

4.9

Overall Experience
173 Reviews
Dr. Algazi is the BEST! He has called me on his days off to explain about meds. I feel so blessed to have him as my doctor.
Explained things in a way that was easy to understand
173 Reviews
Did the doctor pay attention to your concerns
173 Reviews
Gave easy to understand instructions about taking care of health problems or concerns
171 Reviews
Knew the important information about your medical history
172 Reviews
The provider showed respect for what you had to say
173 Reviews
The provider spent enough time with me
173 Reviews

Selected research

Decorative Caduceus

Phase II Study of Perioperative Immunotherapy in Patients With Advanced Non-Virally Associated ...

Intratumoral CD3+ T-cells will be identified by immunohistochemistry in pre- and post-treatment tumor specimens. The proportion of patients with a >= 40% increase (from pre- to post-treatment) will be calculated. The exact 95% con...

Recruiting

Decorative Caduceus

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Measured using RECIST 1.1

Recruiting

Decorative Caduceus

Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head...

Recruiting

Share